Follow the people · Insider
Stephen P. Robertson
Stephen P. Robertson files insider transactions with the SEC as a chief legal officer of Aurinia Pharmaceuticals (AUPH). We hold 1 disclosed purchase or sale filed since 29 January 2021, 1 of them in the last 90 days.
- Files forAUPH
- Disclosed buys and sells1 in all, 1 in the last 90 days
- Last disclosure25 August 2026
Positions held
1 post we hold — a term names its own dates; a run of filings only says when they filed- Filed 28 January 2021 — 21 August 2026Chief Legal Officer · Aurinia Pharmaceuticals (AUPH)28 Form 4 lines · source: SEC Form 4
Everything they disclosed
28 entries, newest first — one per disclosure report, one per Form 4 line- ▼ sold on the open market 20,975 shares of Aurinia PharmaceuticalsSEC Form 425 August 2026Common Stock · traded 21 August 2026 · filed 25 August 2026
- was granted 115,541 shares of Aurinia PharmaceuticalsSEC Form 420 May 2026Common Stock · traded 18 May 2026 · filed 20 May 2026
- was granted 59,090 shares of Aurinia PharmaceuticalsSEC Form 43 March 2026Common Stock · traded 27 February 2026 · filed 3 March 2026
- had shares withheld for tax on 36,525 shares of Aurinia PharmaceuticalsSEC Form 43 March 2026Common Stock · traded 2 March 2026 · filed 3 March 2026
- was granted 98,813 shares of Aurinia Pharmaceuticals (a derivative holding)SEC Form 43 March 2026Employee Stock Option (right to buy) · traded 27 February 2026 · filed 3 March 2026
- was granted 98,813 shares of Aurinia Pharmaceuticals (a derivative holding)SEC Form 43 March 2026Employee Stock Option (right to buy) · traded 27 February 2026 · filed 3 March 2026
- was granted 59,090 shares of Aurinia PharmaceuticalsSEC Form 43 March 2026Common Stock · traded 27 February 2026 · filed 3 March 2026
- had shares withheld for tax on 36,525 shares of Aurinia PharmaceuticalsSEC Form 43 March 2026Common Stock · traded 2 March 2026 · filed 3 March 2026
- had shares withheld for tax on 34,638 shares of Aurinia PharmaceuticalsSEC Form 423 February 2026Common Stock · traded 20 February 2026 · filed 23 February 2026
- had shares withheld for tax on 34,638 shares of Aurinia PharmaceuticalsSEC Form 423 February 2026Common Stock · traded 20 February 2026 · filed 23 February 2026
- was granted 48,558 shares of Aurinia PharmaceuticalsSEC Form 45 January 2026Common Stock · traded 2 January 2026 · filed 5 January 2026
- had shares withheld for tax on 40,385 shares of Aurinia PharmaceuticalsSEC Form 45 January 2026Common Stock · traded 2 January 2026 · filed 5 January 2026
- was granted 48,558 shares of Aurinia PharmaceuticalsSEC Form 45 January 2026Common Stock · traded 2 January 2026 · filed 5 January 2026
- had shares withheld for tax on 40,385 shares of Aurinia PharmaceuticalsSEC Form 45 January 2026Common Stock · traded 2 January 2026 · filed 5 January 2026
- was granted 128,438 shares of Aurinia Pharmaceuticals (a derivative holding)SEC Form 44 March 2025Employee Stock Option (right to buy) · traded 28 February 2025 · filed 4 March 2025
- was granted 84,106 shares of Aurinia PharmaceuticalsSEC Form 44 March 2025Common Stock · traded 28 February 2025 · filed 4 March 2025
- was granted 102,406 shares of Aurinia PharmaceuticalsSEC Form 44 March 2025Common Stock · traded 3 March 2025 · filed 4 March 2025
- ▼ sold on the open market 64,872 shares of Aurinia PharmaceuticalsSEC Form 44 March 2025Common Stock · traded 3 March 2025 · filed 4 March 2025
- ▼ sold on the open market 57,607 shares of Aurinia PharmaceuticalsSEC Form 44 March 2025Common Stock · traded 4 March 2025 · filed 4 March 2025
- ▼ sold on the open market 57,745 shares of Aurinia PharmaceuticalsSEC Form 47 March 2024Common Stock · traded 6 March 2024 · filed 7 March 2024
- ▼ sold on the open market 19,644 shares of Aurinia PharmaceuticalsSEC Form 422 February 2024Common Stock · traded 2 March 2023 · filed 22 February 2024
- was granted 194,230 shares of Aurinia PharmaceuticalsSEC Form 422 February 2024Common Stock · traded 20 February 2024 · filed 22 February 2024
- was granted 204,810 shares of Aurinia PharmaceuticalsSEC Form 46 March 2023Common Stock · traded 2 March 2023 · filed 6 March 2023
- ▼ sold on the open market 19,402 shares of Aurinia PharmaceuticalsSEC Form 46 March 2023Common Stock · traded 2 March 2023 · filed 6 March 2023
- was granted 104,080 shares of Aurinia Pharmaceuticals (a derivative holding)SEC Form 44 March 2022Restricted Stock Unit · traded 2 March 2022 · filed 4 March 2022
- was granted 178,063 shares of Aurinia Pharmaceuticals (a derivative holding)SEC Form 44 March 2022Stock Option (right to buy) · traded 2 March 2022 · filed 4 March 2022
- was granted 8,500 shares of Aurinia PharmaceuticalsSEC Form 44 March 2022Common Stock · traded 2 March 2022 · filed 4 March 2022
- ▲ bought on the open market 900 shares of Aurinia PharmaceuticalsSEC Form 429 January 2021Common Stock · traded 28 January 2021 · filed 29 January 2021
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.